GCM
OFIX icon

Glenview Capital Management’s Orthofix Medical OFIX Stock Holding History

Glenview Capital Management’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-63,196
Closed -$987K – 46
2024
Q3 		$987K Sell
63,196
-1,041,857
-94% -$16.7M 0.02% 44
2024
Q2 		$14.7M Buy
1,105,053
+221,928
+25% +$3.04M 0.29% 37
2024
Q1 		$12.8M Buy
883,125
+383,125
+77% +$5.3M 0.22% 38
2023
Q4 		$6.74M Buy
+500,000
New +$5.87M 0.14% 39

Other funds holding OFIX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
BCM
Boone Capital Management Atlanta, Georgia $326M AUM 86.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Glenview Capital Management's OFIX Position: Q4 2024 in Review

Glenview Capital Management sold out of Orthofix Medical (OFIX) in Q4 2024, closing a stake of 63,196 shares — an estimated $987K sold.

Glenview Capital Management first reported a position in OFIX in Q4 2023 and held it in 4 quarters. The position peaked at $14.7M in Q2 2024. 149 funds tracked by Wall St. Rank hold OFIX as of Q4 2024.

  • Glenview Capital Management reported no remaining Orthofix Medical position as of Q4 2024 after selling out during the quarter.
  • Glenview Capital Management sold 63,196 Orthofix Medical shares in Q4 2024, an estimated $987K.
  • Glenview Capital Management first reported a position in Orthofix Medical in Q4 2023 and held it in 4 quarters.
  • Glenview Capital Management's Orthofix Medical position peaked at $14.7M in Q2 2024.
  • 149 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2024.

Based on Glenview Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.